Filter Search


Healthcare and Medical


Location Summary Deadline
Germany Open House Biologika Discount Contracts 2025-26-insulin Lispro (atc: A10ab04, Effectiveness: 100 U/ml) 2026-03-09
Germany Conclusion Of A Non-exclusive Discount Agreement According To § 130a Abs. 8 Sgb V For Pharmaceuticals Containing The Active Ingredient Tocilizumab. Tocilizumab 2026-03-09
Germany Conclusion Of A Non-exclusive Discount Agreement According To § 130a Para. 8 Sgb V For Pharmaceuticals Containing The Active Ingredient Tocilizumab. Tocilizumab 2026-03-09
Germany Conclusion Of A Non-exclusive Discount Agreement According To § 130a Abs. 8 Sgb V For Pharmaceuticals Containing The Active Ingredient Tocilizumab. Tocilizumab 2026-03-09
Germany Completion Of A Non -exclusive Discount Contract According To § 130a Para. 8 Sgb V To Drugs With The Active Ingredient Budesonide (except Inhalativa And At Least With An Approval For The Indication Of Chronic Inflammatory Bowel Disease) (atccode 2026-03-09
Thailand Announcement Of Bidding For The Purchase Of 2 Electric Cesarean Section Beds 2026-03-09
Thailand Announcement Of Bidding For The Purchase Of 2 Incubators 2026-03-09
Thailand Announcement Of The Price Purchase Of A High-frequency Sound Wave Cardiac Detector. Four-dimensional Type (echocardiography) Number 1 Machine. 2026-03-09
Germany Open House Biologika Discount Contracts 2025-26-insulin Lispro (atc: A10ab04, Effectiveness: 100 U/ml) 2026-03-09
Germany Robot-assisted Surgery System 2026-03-09
Whats app